Ralph B. D'Agostino Sr. American biostatistician
D'Agostino, Ralph B.
D'Agostino, Ralph B., 1940-....
VIAF ID: 59192347 (Personal)
Permalink: http://viaf.org/viaf/59192347
Preferred Forms
- 200 _ | ‡a D'Agostino ‡b Ralph B. ‡f 1940-....
-
-
- 100 1 _ ‡a D'Agostino, Ralph B ‡d 1940-
-
-
-
- 100 1 _ ‡a D'Agostino, Ralph B.
-
-
- 100 1 _ ‡a D'Agostino, Ralph B.
- 100 1 _ ‡a D'Agostino, Ralph B.
- 100 1 _ ‡a D'Agostino, Ralph B.
-
-
-
- 100 1 _ ‡a D'Agostino, Ralph B., ‡d 1940-....
- 100 0 _ ‡a Ralph B. D'Agostino Sr. ‡c American biostatistician
4xx's: Alternate Name Forms (18)
Works
Title | Sources |
---|---|
Best paper of the 1980s: National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making. 1988. | |
Biosimilar clinical development, 2017: | |
Coronary artery calcium score–directed primary prevention with statins on the basis of the 2018 American College of Cardiology/American Heart Association/multisociety cholesterol guidelines | |
Factor analysis : an applied approach | |
Goodness-of-fit techniques | |
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons | |
Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events | |
Managing and analysing data from a large-scale study on Framingham Offspring relating brain structure to cognitive function | |
Mathematical modeling, applications in emergency health services | |
Means at each examination and inter-examination consistency of specified characteristics : Farmingham heart study, 30 year follow-up | |
Odyssey | |
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. | |
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. | |
Parental intermittent claudication as risk factor for claudication in adults | |
Perceptions of leader attributes and satisfaction with mil. life, 1978 (a.e.) | |
Practical engineering statistics | |
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort | |
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration | |
The prevention and treatment of missing data in clinical trials | |
The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma | |
The randomized registry trial--the next disruptive technology in clinical research? | |
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. | |
The Reply | |
The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study | |
Statistical methods in clinical studies | |
Statistical modelling of complex medical data | |
Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary | |
Sudden coronary death in women. | |
Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections | |
Surfactant trials. | |
Surrogate markers: back to the future | |
Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib. | |
Survival and functional status 20 or more years after first stroke: the Framingham Study. | |
Survival following initial cardiovascular events ; thirty year follow-up | |
Symposium on Longitudinal Data Analysis, 19-21 June 1991 | |
Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence | |
Temporal Patterns of Stroke Onset | |
Temporal trends in self-reported functional limitations and physical disability among the community-dwelling elderly population: the Framingham heart study | |
Thoroughly modern risk prediction? | |
Trajectories of Entering the Metabolic Syndrome | |
Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types | |
Trends in CHD and risk factors at age 55-64 in the Framingham Study | |
Trends in the association of parental history of obesity over 60 years | |
Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. | |
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. | |
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2 T-type voltage-gated calcium channels and Ca2+ influx | |
Tutorials in biostatistics. | |
Understanding increments in model performance metrics. | |
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. | |
Update on fibrinogen as a cardiovascular risk factor | |
Updating our aims and scope for the future. | |
Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease | |
Use of composite endpoints in clinical trials | |
Use of renin-angiotensin inhibitors in people with renal artery stenosis | |
Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy | |
Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all. | |
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance | |
Using survival methods to estimate age-at-onset distributions for genetic diseases with an application to Huntington disease | |
Utilization of absolute monocyte counts to predict cardiovascular events in people living with HIV | |
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension | |
Validation of a dietary pattern approach for evaluating nutritional risk: the Framingham Nutrition Studies | |
Validation of an atrial fibrillation risk algorithm in whites and African Americans | |
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | |
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study | |
Variability of body weight and health outcomes in the Framingham population | |
Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. | |
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry | |
Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study | |
Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment | |
Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? | |
Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study | |
Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study | |
Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study) | |
Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. | |
What to expect from net reclassification improvement with three categories | |
Widespread pain is a risk factor for cardiovascular mortality: results from the Framingham Heart Study | |
Wiley encyclopedia of clinical trials | |
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics. | |
هایپرینسولینمی ، هایپرگلیسمی و هموستاز مختل شده: مطالعه فرزندان فرامینگهام. | |
সম্পাদকীয় | |
통계 수와 그래프로 통쾌하게 세상 꿰뚫기 |